Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus

Anna M Grandi1, Eliana Piantanida, Ivano Franzetti

  • 1Department of Clinical Medicine, University of Insubria, Insubria, Italy. amgrandi@libero.it

Insights

Improving glycemic control in type 1 diabetes can significantly enhance left ventricular (LV) diastolic function. Tight blood sugar management may prevent or reverse diastolic dysfunction in diabetic heart disease.

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic heart disease is often characterized by left ventricular (LV) diastolic dysfunction.
  • Type 1 diabetes mellitus (T1DM) poses a significant risk for cardiovascular complications.
  • Effective management of hyperglycemia is crucial for mitigating diabetic complications.

Purpose of the Study:

  • To investigate the impact of improved glycemic control on LV diastolic function in individuals with T1DM.
  • To assess the relationship between glycated hemoglobin levels and diastolic parameters over time.
  • To determine if enhanced glycemic control can ameliorate or prevent diastolic dysfunction in T1DM.

Main Methods:

  • Prospective study involving 36 normotensive T1DM patients with inadequately controlled glycemia (HbA1c >7%).
  • Insulin therapy was adjusted to improve glycemic control over 6 and 12 months.
  • Evaluations included glycated hemoglobin, LV echocardiography, 24-hour blood pressure monitoring, and laboratory tests.

Main Results:

  • After 6 months, mean glycated hemoglobin significantly decreased, and LV diastolic parameters showed significant improvement.
  • LV anatomy and systolic function remained unchanged, indicating isolated diastolic dysfunction improvement.
  • Changes in diastolic parameters were inversely correlated with changes in glycated hemoglobin.

Conclusions:

  • A strong association exists between glycemic control and LV diastolic function in normotensive T1DM patients.
  • Improved glycemic control leads to significant improvements in diastolic function.
  • Tight glycemic control offers a potential strategy for preventing or reversing diastolic dysfunction in T1DM.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...